Fig. 5From: Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysisComparing bleeding events observed with double dose clopidogrel versus ticagrelor or prasugrelBack to article page